Come up with a name for your new list and we'll add to it:
Bonti raised a round of funding on January 23, 2018. Investors include
City Hill Ventures.
Bonti, formerly Endurance Biotech, is focused on developing next generation neurotoxins through its proprietary platform for treating indications with strong unmet needs.…